Noninvasive diagnostic tests for Helicobacter pylori infection in children

Area of Science:

• Pediatric Gastroenterology
• Infectious Diseases
• Diagnostic Testing

Background:

• Accurate diagnosis of Helicobacter pylori infection is crucial in children, especially in low-prevalence populations.
• Noninvasive tests are preferred for initial diagnosis and monitoring eradication therapy success.
• High sensitivity and specificity are required for reliable clinical decision-making in pediatric patients.

Purpose of the Study:

• To evaluate the diagnostic accuracy of noninvasive tests for Helicobacter pylori infection in children.
• To identify the most reliable noninvasive method for pediatric H. pylori diagnosis and post-treatment monitoring.

Main Methods:

• Systematic review and analysis of existing studies on noninvasive H. pylori diagnostic tests in pediatric populations.
• Comparison of the 13C-urea breath test, stool antigen tests (enzyme immunoassays), and serological/other noninvasive methods.
• Assessment of sensitivity and specificity data, particularly in children and post-treatment scenarios.

Main Results:

• The 13C-urea breath test has demonstrated validated high sensitivity and specificity in diverse pediatric age groups across multiple countries.
• Stool antigen enzyme immunoassays show promise but require further validation, especially for post-treatment assessment in children.
• Other noninvasive methods, including serological tests and alternative stool tests, exhibit limited accuracy compared to the 13C-urea breath test.

Conclusions:

• The 13C-urea breath test is currently the recommended noninvasive diagnostic standard for Helicobacter pylori infection in children.
• Further research and larger studies are needed to validate stool antigen tests for routine pediatric use.
• Less accurate noninvasive tests are not recommended for clinical decision-making in pediatric H. pylori management.